Zhen Zhou

3.0k total citations · 1 hit paper
41 papers, 1.7k citations indexed

About

Zhen Zhou is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Zhen Zhou has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Zhen Zhou's work include MicroRNA in disease regulation (23 papers), Circular RNAs in diseases (10 papers) and Cancer-related molecular mechanisms research (10 papers). Zhen Zhou is often cited by papers focused on MicroRNA in disease regulation (23 papers), Circular RNAs in diseases (10 papers) and Cancer-related molecular mechanisms research (10 papers). Zhen Zhou collaborates with scholars based in China, United States and Czechia. Zhen Zhou's co-authors include Ke Zen, Chen‐Yu Zhang, Xi Chen, Hongwei Liang, Zheng Fu, Meng Ding, Dongxia Hou, Cheng Wang, Xiaohong Jiang and Chen-Yu Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Zhen Zhou

40 papers receiving 1.7k citations

Hit Papers

Small extracellular vesicles from young plasma reverse ag... 2024 2026 2025 2024 20 40 60

Peers

Zhen Zhou
Hae Kyung Lee South Korea
Zhen Zhou
Citations per year, relative to Zhen Zhou Zhen Zhou (= 1×) peers Hae Kyung Lee

Countries citing papers authored by Zhen Zhou

Since Specialization
Citations

This map shows the geographic impact of Zhen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Zhou more than expected).

Fields of papers citing papers by Zhen Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Zhou. The network helps show where Zhen Zhou may publish in the future.

Co-authorship network of co-authors of Zhen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Zhou. A scholar is included among the top collaborators of Zhen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Zhou. Zhen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Huanhuan, Rongjie Cheng, Yanbo Wang, et al.. (2022). Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. Journal of Clinical Investigation. 133(2). 71 indexed citations
2.
Li, Mingyi, Chenxia Li, Huarong Zheng, et al.. (2022). CircRNA_0001795 sponges miRNA-339-5p to regulate yes-associated protein 1 expression and attenuate osteoporosis progression. Bioengineered. 13(2). 2803–2815. 27 indexed citations
3.
Wang, Cheng, Nan Zhang, Meng Ding, et al.. (2022). Increased serum piwi-interacting RNAs as a novel potential diagnostic tool for brucellosis. Frontiers in Cellular and Infection Microbiology. 12. 992775–992775. 4 indexed citations
4.
Jin, Liang, Shiyong Xin, Zhen Zhou, et al.. (2022). Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer. Frontiers in Immunology. 13. 974034–974034. 19 indexed citations
5.
Wang, Yanbo, Zhang‐Peng Chen, Huanhuan Hu, et al.. (2021). Sperm microRNAs confer depression susceptibility to offspring. Science Advances. 7(7). 78 indexed citations
6.
Wang, Yanbo, Xiaming Jiang, Zheng Fu, et al.. (2021). Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients. Signal Transduction and Targeted Therapy. 6(1). 300–300. 55 indexed citations
7.
Liu, Chunyan, Mengzhen Xu, Yulian Wang, et al.. (2021). Honeysuckle-derived microRNA2911 inhibits tumor growth by targeting TGF-β1. Chinese Medicine. 16(1). 49–49. 27 indexed citations
8.
Zhou, Zhen, Yishan Zheng, Xi Chen, et al.. (2020). Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients. Cell Discovery. 6(1). 54–54. 123 indexed citations
9.
Gong, Ting, Xin Gu, Yuting Liu, et al.. (2020). Both combinatorial K4me0-K36me3 marks on sister histone H3s of a nucleosome are required for Dnmt3a-Dnmt3L mediated de novo DNA methylation. Journal of genetics and genomics. 47(2). 105–114. 6 indexed citations
10.
Han, Jiayi, Wu Sun, Rui Liu, et al.. (2020). Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma. Frontiers in Oncology. 10. 1495–1495. 29 indexed citations
11.
Gao, Zhiying, Likun Zhou, Huan Wu, et al.. (2020). miR-24-3p promotes colon cancer progression by targeting ING1. Signal Transduction and Targeted Therapy. 5(1). 171–171. 19 indexed citations
12.
Zhang, Wen, Xiaona Li, Lina Ma, et al.. (2018). Identification of microRNA-like RNAs in Ophiocordyceps sinensis. Science China Life Sciences. 62(3). 349–356. 12 indexed citations
13.
Hou, Dongxia, Fangfang He, Lina Ma, et al.. (2018). The potential atheroprotective role of plant MIR156a as a repressor of monocyte recruitment on inflamed human endothelial cells. The Journal of Nutritional Biochemistry. 57. 197–205. 83 indexed citations
14.
Ding, Meng, Cheng Wang, Xiaolan Lu, et al.. (2018). Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling. Analytical and Bioanalytical Chemistry. 410(16). 3805–3814. 132 indexed citations
15.
Niu, Xiaomin, Fatao Liu, Yi Zhou, et al.. (2017). Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment. Clinical Cancer Research. 23(17). 5003–5014. 16 indexed citations
16.
Wang, Yanbo, Hongwei Liang, Qian Fan, et al.. (2017). miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer. Cell Death and Disease. 8(10). e3059–e3059. 61 indexed citations
17.
Liu, M., Kai Yin, Xu Guo, et al.. (2017). Diphthamide Biosynthesis 1 is a Novel Oncogene in Colorectal Cancer Cells and is Regulated by MiR-218-5p. Cellular Physiology and Biochemistry. 44(2). 505–514. 14 indexed citations
18.
Xue, Yunxing, Zhe Wei, Hanying Ding, et al.. (2015). MicroRNA-19b/221/222 induces endothelial cell dysfunction via suppression of PGC-1α in the progression of atherosclerosis. Atherosclerosis. 241(2). 671–681. 127 indexed citations
19.
Liang, Hongwei, Zhen Zhou, Suyang Zhang, et al.. (2014). Identification of Ebola virus microRNAs and their putative pathological function. Science China Life Sciences. 57(10). 973–981. 43 indexed citations
20.
Xu, Jie, Xi Chen, Donghai Li, et al.. (2014). Small RNA existed in commercial reverse transcriptase: primary evidence of functional small RNAs. Protein & Cell. 6(1). 1–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026